Schonfeld Strategic Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-199,024	Closed	-$4.29M	–	2157
2025 Q2	$4.29M	Buy	+199,024	New	+$3.7M	0.03%	614
2025 Q1	–	Sell	-69,169	Closed	-$1.27M	–	2175
2024 Q4	$1.27M	Buy	69,169 +30,232	+78%	+$488K	0.01%	1021
2024 Q3	$599K	Sell	38,937 -15,406	-28%	-$257K	﹤0.01%	1357
2024 Q2	$883K	Sell	54,343 -13,996	-20%	-$226K	0.01%	1262
2024 Q1	$1.26M	Buy	+68,339	New	+$1.69M	0.01%	1142
2023 Q4	–	Sell	-79,700	Closed	-$1.66M	–	1831
2023 Q3	$1.66M	Buy	79,700 +5,033	+7%	+$137K	0.02%	877
2023 Q2	$1.79M	Buy	+74,667	New	+$1.66M	0.02%	784
2022 Q2	–	Sell	-33,900	Closed	-$821K	–	2470
2022 Q1	$821K	Buy	+33,900	New	+$820K	0.01%	1089
2021 Q4	–	Sell	-33,200	Closed	-$552K	–	2084
2021 Q3	$552K	Sell	33,200 -14,473	-30%	-$279K	0.01%	1213
2021 Q2	$1.16M	Buy	47,673 +32,271	+210%	+$728K	0.01%	878
2021 Q1	$397K	Buy	+15,402	New	+$678K	0.01%	1225
2020 Q4	–	Sell	-39,629	Closed	-$1.64M	–	1528
2020 Q3	$1.64M	Buy	39,629 +16,676	+73%	+$720K	0.03%	569
2020 Q2	$1.11M	Buy	+22,953	New	+$1.1M	0.03%	577
2020 Q1	–	Sell	-5,017	Closed	-$214K	–	1096
2019 Q4	$214K	Buy	+5,017	New	+$218K	0.01%	1144
2019 Q3	–	Sell	-297,300	Closed	-$7.95M	–	997
2019 Q2	$7.95M	Buy	297,300 +202,300	+213%	+$5.17M	0.28%	89
2019 Q1	$2.55M	Buy	95,000 +13,000	+16%	+$304K	0.09%	284
2018 Q4	$1.33M	Sell	82,000 -20,900	-20%	-$406K	0.05%	407
2018 Q3	$2.14M	Buy	102,900 +78,400	+320%	+$1.23M	0.1%	270
2018 Q2	$375K	Sell	24,500 -78,661	-76%	-$1.4M	0.02%	590
2018 Q1	$2.32M	Buy	+103,161	New	+$2.86M	0.17%	167
2017 Q1	–	Sell	-26,944	Closed	-$777K	–	577
2016 Q4	$777K	Sell	26,944 -9,814	-27%	-$260K	0.1%	262
2016 Q3	$1.17M	Sell	36,758 -4,210	-10%	-$143K	0.2%	146
2016 Q2	$1.33M	Buy	40,968 +3,172	+8%	+$106K	0.3%	92
2016 Q1	$1.06M	Buy	+37,796	New	+$824K	0.43%	62